Singapore: Australia on Friday stopped a vaccine trial in phase 1 after several participants developed antibodies for HIV, though it’s not a serious side effect.
The vaccine, developed by University of Queensland (UQ) in collaboration with biotech company CSL, was tested on 216 people. The University has further tested the patients and confirmed that there is no HIV virus present in their body.
Some participants developed antibodies towards fragments of a HIV protein (gp41), which was used to stabilise the vaccine, the University said.
After that, it was decided that phase 2 and 3 trials will not be carried out.
The Australian government had committed to buy 51 million doses of this experimental vaccine and 3 others.
Australian Prime Minister Scott Morrison sounded practical. “What happened today is not a surprise to the Government. We are moving swiftly but not with any undue haste.”
Bhubaneswar: After Odisha’s Forest Minister Ganesh Ram Singh Khuntia’s direction for through probe into elephant…
Bhubaneswar: Following backlash on social media, popular e-commerce platform Meesho on Tuesday removed t-shirts, featuring…
New Delhi: India has taken the first step in its attempt to host the 2036…
Bhadrak: The Railways on Tuesday launched a probe into allegations of bullets being fired at…
Bhubaneswar: Odisha Vigilance on Tuesday arrested senior assistant in Additional District Public Health Office (Family…
Bhubaneswar: The regional centre of India Meteorological Department (IMD) has sounded yellow warning for four…
Bhubaneswar: Odisha’s Deputy Chief Minister Pravati Parida held a meeting with the Indian High Commissioner…
Bhubaneswar: Chief Minister Mohan Charan Majhi on Tuesday informed about the central government's plans for…